Video

Dr. Sam on Mitigating Risk of COVID-19 in Elderly Patients With Cancer

Christine Sam, MD, discusses strategies to mitigate the risk of the coronavirus disease 2019 in elderly patients with cancer.

Christine Sam, MD, hematologist and oncologist, assistant member, Department of Individualized Cancer Management/Senior Adult Oncology Program, Moffitt Cancer Center, discusses strategies to mitigate the risk of the coronavirus disease 2019 (COVID-19) in elderly patients with cancer.

Elderly patients with cancer are at an increased risk of contracting COVID-19, Sam says.

As such, practicing social distancing, wearing masks, performing good hand hygiene, and avoiding touching their faces are potential strategies patients can use to mitigate this risk, explains Sam. Additionally, ensuring that patients are up to date on their vaccinations is critical to minimize the risk of pneumonia in this population.

Typically, older patients come to the clinic more often than younger patients, Sam says.

Given the COVID-19 pandemic, improving telehealth options, increasing geriatric-friendly alternatives to telemedicine, and providing supplemental education or IT support can make elderly patients more comfortable with using telehealth options, concludes Sam.

Related Videos
Viktor Grünwald, MD, PhD
Aaron Gerds, MD
Christine M. Lovly, MD, PhD, Ingram Associate Professor of Cancer Research, associate professor, medicine (hematology/oncology), Vanderbilt-Ingram Cancer Center
Haeseong Park, MD, MPH
David L. Porter, MD
Timothy Yap, MBBS, PhD, FRCP
Leo I. Gordon, MD, Abby and John Friend Professor of Oncology Research, professor, medicine (hematology and oncology), Feinberg School of Medicine, Robert H. Lurie Cancer Center
Hetty E. Carraway, MD, MBA, staff associate professor, Department of Medicine, School of Medicine, Cleveland Clinic Lerner College of Medicine of Case Western Reserve University; member, Immune Oncology Program, Case Comprehensive Cancer Center; vice chair, Strategy and Enterprise Development, Taussig Cancer Institute, Division of Hematologic Oncology and Blood Disorders, Cleveland Clinic
David A. Braun, MD, PhD, assistant professor, medicine (medical oncology), Louis Goodman and Alfred Gilman Yale Scholar, member, Center of Molecular and Cellular Oncology, Yale Cancer Center
Julia Foldi, MD, PhD